tiprankstipranks
MAIA Biotechnology, Inc. (MAIA)
NYSE MKT:MAIA
US Market

MAIA Biotechnology, Inc. (MAIA) Income Statement

106 Followers

MAIA Biotechnology, Inc. Income Statement

Last quarter (Q1 2024), MAIA Biotechnology, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q1, MAIA Biotechnology, Inc.'s net income was $-8.07M. See MAIA Biotechnology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 20.00M$ 20.18M$ -16.18M$ 7.74M$ 6.98M
Operating Income
$ -20.00M$ -20.18M$ -15.86M$ -7.74M$ -6.98M
Net Non Operating Interest Income Expense
$ 76.56K$ 27.63K$ -5.10K$ -825.53K$ -31.55K
Other Income Expense
$ 4.00M$ -205.13K$ -98.39K$ -4.01M$ 47.90K
Pretax Income
$ -23.74M$ -19.77M$ -15.77M$ -12.58M$ -6.96M
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -23.72M$ -19.77M$ -16.22M$ -12.50M$ -6.64M
Basic EPS
$ -1.57$ -1.49$ -1.75$ -1.18$ -0.62
Diluted EPS
$ -1.57$ -1.49$ -1.75$ -1.18$ -0.62
Basic Average Shares
$ 59.67M$ 13.26M$ 9.28M$ 10.64M$ 10.64M
Diluted Average Shares
$ 59.67M$ 13.26M$ 9.28M$ 10.64M$ 10.64M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 20.00M$ 20.18M$ -16.18M$ 7.74M$ 6.98M
Net Income From Continuing And Discontinued Operation
$ -23.72M$ -19.77M$ -15.77M$ -12.50M$ -6.64M
Normalized Income
$ -16.80M$ -15.62M-$ -8.49M$ -6.68M
Interest Expense
---$ 827.54K$ 32.23K
EBIT
$ -23.74M$ -19.77M$ -15.76M$ -11.75M$ -6.93M
EBITDA
$ -23.74M$ -19.77M$ -15.76M$ -11.75M$ -6.93M
Currency in USD

MAIA Biotechnology, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis